Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT07837648
PHASE1

A Study to Test How Much BI 3034701 Gets Into the Blood in Healthy People When Given in Two Different Ways

Sponsor: Boehringer Ingelheim

View on ClinicalTrials.gov

Summary

The aim of the trial is to investigate relative bioavailability of BI 3034701 treatment T vs. BI 3034701 treatment R.

Official title: Relative Bioavailability of Two Different BI 3034701 Treatments Following Subcutaneous Administration in Healthy Male and Female Participants (an Open-label, Randomised, Single-dose, Two-period, Two-sequence, Crossover Trial)

Key Details

Gender

All

Age Range

18 Years - 55 Years

Study Type

INTERVENTIONAL

Enrollment

30

Start Date

2026-10-05

Completion Date

2026-12-24

Last Updated

2026-10-19

Healthy Volunteers

Yes

Conditions

Interventions

DRUG

BI3034701 formulation II

BI3034701 formulation II (reference treatment)

DRUG

BI3034701 formulation C1

BI3034701 formulation C1 (test treatment)

Locations (1)

Quotient Sciences

Nottingham, United Kingdom